Arcede Pharma is a pharmaceutical company. The company conducts research and development in the area of chronic obstructive pulmonary disease, including abbreviated COPD, and severe asthma. The company's product portfolio includes a number of drugs intended for the treatment and alleviation of the above ailments. The largest operations are in the Nordic market. The company was established via a spin-off of Respiratorius in 2022 and is headquartered in Lund.

Quotes for Arcede Pharma AB

Right Now

+/-
-0.01
%
-0,50%
Latest
1.975
High
2.09
Low
1.845
Volume
3 322
Turnover (SEK)
6 666
Market Value (MSEK)
11,5
Time (Latest trade)
2023-05-29 12:39

Board

CEO

  • Mia Lundblad

Chairperson of the Board

  • Ingemar Kihlström

Board

  • Åsa Kornfeld
  • Johanna Asklin
  • Laurent Pacheco

Largest Owners

Name Capital % Votes % Date
Christer Fåhraeus 11,24 11,24 2023-03-29
Avanza Pension 5,99 5,99 2023-03-29
Valcuria Holding AB 3,86 3,86 2023-03-29
Ben Hayes 2,34 2,34 2023-03-29
Hans Harvig 1,72 1,72 2023-03-29
Hans Jonsson 1,71 1,71 2023-03-29
Linnart Shabo 1,70 1,70 2023-03-29
Nordnet Pensionsförsäkring 1,46 1,46 2023-03-29
Andreas Bylin 1,24 1,24 2023-03-29
Ted Nilsson 1,07 1,07 2023-03-29
** Holdings by Modular Finance AB. Compiled and processed data from various sources, including Euroclear, Morningstar and the Swedish Financial Supervisory Authority.

Insider trading

Key Numbers

*Compiled data from Millistream

Upcoming reports

  • 2023-08-28 Delårsrapport 2023-Q2

  • 2023-11-10 Delårsrapport 2023-Q3